Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolically healthy obesity: facts and fantasies
Gordon I. Smith, Bettina Mittendorfer, Samuel Klein
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 3978-3989
Open Access | Times Cited: 481

Showing 1-25 of 481 citing articles:

Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Marie‐Ève Piché, André Tchernof, Jean–Pierre Després
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1477-1500
Open Access | Times Cited: 1302
Inflammation in obesity, diabetes, and related disorders
Theresa V. Rohm, Daniel T. Meier, Jerrold M. Olefsky, et al.
Immunity (2022) Vol. 55, Iss. 1, pp. 31-55
Open Access | Times Cited: 1107
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 1031
Adipose-tissue plasticity in health and disease
Alexander P. Sakers, Mirian Krystel De Siqueira, Patrick Seale, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 419-446
Open Access | Times Cited: 516
Why does obesity cause diabetes?
Samuel Klein, Amalia Gastaldelli, Hannele Yki‐Järvinen, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 11-20
Open Access | Times Cited: 482
Causes, consequences, and treatment of metabolically unhealthy fat distribution
Norbert Stefan
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 7, pp. 616-627
Closed Access | Times Cited: 430
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 398
Obesity, Inflammation, and Immune System in Osteoarthritis
Udhaya Nedunchezhiyan, Ibin Varughese, Antonia Rujia Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 251
β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
Laura I. Hudish, Jane E.B. Reusch, Lori Sussel
Journal of Clinical Investigation (2019) Vol. 129, Iss. 10, pp. 4001-4008
Open Access | Times Cited: 250
Obesity and the risk of cardiometabolic diseases
Pedro L. Valenzuela, Pedro Carrera‐Bastos, Adrián Castillo‐García, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 7, pp. 475-494
Closed Access | Times Cited: 212
ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes
Yu Sun, Yifan Lu, Jason Saredy, et al.
Redox Biology (2020) Vol. 37, pp. 101696-101696
Open Access | Times Cited: 207
Chronic tissue inflammation and metabolic disease
Yun Sok Lee, Jerrold M. Olefsky
Genes & Development (2021) Vol. 35, Iss. 5-6, pp. 307-328
Open Access | Times Cited: 196
Obesity, metabolic syndrome, and primary hypertension
Mieczysław Litwin, Zbigniew Kułaga
Pediatric Nephrology (2020) Vol. 36, Iss. 4, pp. 825-837
Open Access | Times Cited: 170
The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities
Holger Steinbrenner, Leonidas H. Duntas, Margaret P. Rayman
Redox Biology (2022) Vol. 50, pp. 102236-102236
Open Access | Times Cited: 153
Obesity, kidney dysfunction, and inflammation: interactions in hypertension
John E. Hall, Alan J. Mouton, Alexandre A. da Silva, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 8, pp. 1859-1876
Open Access | Times Cited: 148
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Sandra Rayego‐Mateos, Raúl R. Rodrigues-Díez, Beatriz Fernández‐Fernández, et al.
Kidney International (2022) Vol. 103, Iss. 2, pp. 282-296
Closed Access | Times Cited: 145
Adiponectin, Leptin and Cardiovascular Disorders
Shangang Zhao, Christine M. Kusminski, Philipp E. Scherer
Circulation Research (2021) Vol. 128, Iss. 1, pp. 136-149
Open Access | Times Cited: 140
Obese visceral fat tissue inflammation: from protective to detrimental?
Hubert Kolb
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 137
The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study
John Stephenson, Christine Smith, Benjamin Kearns, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 125
Obesity I: Overview and molecular and biochemical mechanisms
Robert H. Lustig, David Collier, Christopher D. Kassotis, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115012-115012
Open Access | Times Cited: 125
Anthropometric Indicators as a Tool for Diagnosis of Obesity and Other Health Risk Factors: A Literature Review
Paola Piqueras, Alfredo Ballester, Juan V. Durá‐Gil, et al.
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 121
Obesity and insulin resistance: Pathophysiology and treatment
Yue Tong, Sai Xu, Lili Huang, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 3, pp. 822-830
Closed Access | Times Cited: 112
Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
Norbert Stefan, Matthias B. Schulze
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 6, pp. 426-440
Closed Access | Times Cited: 102
An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Eun Young Lee, Hannelie Korf, António Vidal-Puig
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1048-1062
Open Access | Times Cited: 100
Beyond BMI
George A. Bray
Nutrients (2023) Vol. 15, Iss. 10, pp. 2254-2254
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top